Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 180 for melanoma

Edit search filters
  1. A Study of Immune System Activity Cycles in Patients with Surgically Removed Early Stage Melanoma

    Rochester, MN

  2. MElanoma Research Lymph Node Prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  3. Detection of Mutant Circulating Tumor (CT)Dna in Uveal Melanoma With Development of a Droplet Digital Pcr (Ddpcr) Assay

    Rochester, MN

  4. Innovative CAR-TIL Immunotherapy Against Melanoma

    Jacksonville, FL

  5. Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

  6. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

    Rochester, MN

  7. Two Cancers, One Gene. Why Some People In Families Develop Melanoma Or Pancreas Cancer, While Still Others Never Develop Cancer (TCOG)

    Rochester, MN

  8. A Study Of DNA Markers For The Detection Of Metastatic Melanoma In Blood

    Rochester, MN

  9. Diagnosing Lymphangioleiomyomatosis from Glycoprotein Non-Metastatic Melanoma Protein B

    Rochester, MN

  10. Using Social Media For Public Health Education On Melanoma Within The Hispanic Population

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer